Update on Hormone Replacement: Sorting Out the Options for Preventing Coronary Artery Disease and Osteoporosis

Menopause is associated with an increased risk of osteoporosis and coronary artery disease. The onset of menopause is an excellent time to assess a woman's overall health and the need for hormone replacement therapy (HRT) or other measures to reduce menopausal symptoms, prevent bone loss, and reduce the risk of heart attack. Available HRT can be given in a variety of dosages and formulations, and it can be adjusted to the needs of the individual. If HRT is contraindicated or not accepted, 2 alternative therapies (alendronate and salmon calcitonin) may be offered to treat osteoporosis.